Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Faron Pharmaceuticals Oy
  6. News
  7. Summary
    FARN   FI4000153309

FARON PHARMACEUTICALS OY

(FARN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Faron Pharmaceuticals Oy : Granted US Patent For Cancer Treatment

06/14/2021 | 04:28am EDT


ę MT Newswires 2021
All news about FARON PHARMACEUTICALS OY
10/07FARON PHARMACEUTICALS OY : Exercise of options
AQ
10/05TR-1 : Standard form for notification of major holdings
AQ
10/01FARON PHARMACEUTICALS OY : Registration of Placing Shares with Trade Register
AQ
10/01FARON PHARMACEUTICALS OY : Results of Placing and Issue Price
AQ
09/30FARON PHARMACEUTICALS OY : Proposed Issue and Placing of Shares
AQ
09/17FARON PHARMACEUTICALS OY : Presentation of Updated MATINS Data at ESMO
AQ
09/17Faron Pharmaceuticals Ltd. Announces Updated Results from the Phase I/II MATINS Study
CI
08/26FARON PHARMACEUTICALS OY : Earnings Flash (FARN.L) FARON PHARMACEUTICALS Reports H1 Loss E..
MT
08/26FARON PHARMACEUTICALS OY : Earnings Flash (FARN.L) FARON PHARMACEUTICALS Reports H1 Revenu..
MT
08/26FARON PHARMACEUTICALS OY : Earnings Flash (FARN.L) FARON PHARMACEUTICALS OY Reports H1 Rev..
MT
More news
Financials
Sales 2021 - - -
Net income 2021 -16,8 M -19,5 M -19,5 M
Net cash 2021 10,8 M 12,5 M 12,5 M
P/E ratio 2021 -13,4x
Yield 2021 -
Capitalization 215 M 249 M 249 M
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 30
Free-Float 56,5%
Chart FARON PHARMACEUTICALS OY
Duration : Period :
Faron Pharmaceuticals Oy Technical Analysis Chart | FARN | FI4000153309 | MarketScreener
Technical analysis trends FARON PHARMACEUTICALS OY
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 4,03 €
Average target price 5,75 €
Spread / Average Target 42,6%
EPS Revisions
Managers and Directors
Markku Tapani Jalkanen Chief Executive Officer & Executive Director
Toni Haenninen Chief Financial Officer
Frank Murdoch Armstrong Non-Executive Chairman
Matti Karvonen Chief Medical Officer & VP-Drug Development
Jami Mandelin Research Director
Sector and Competitors
1st jan.Capi. (M$)
FARON PHARMACEUTICALS OY30.77%249
GILEAD SCIENCES, INC.16.15%84 845
BIONTECH SE261.78%71 229
WUXI APPTEC CO., LTD.24.08%64 399
REGENERON PHARMACEUTICALS19.27%59 906
VERTEX PHARMACEUTICALS-21.73%47 992